Table 2.
COVID-19 related treatment and blood values.
| N (%) | |
|---|---|
| Plasma units administered | |
| 1 | 42 (95.5%) |
| 2 | 2 (4.5%) |
| Other therapies | |
| Remdesivir | 32 (72.7%) |
| Tocilizumab | 20 (45.5%) |
| Number of doses | |
| 0 | 24 (54.5%) |
| 1 | 6 (13.6%) |
| 2 | 12 (27.3%) |
| 3 | 2 (4.5%) |
| Anakinra | 11 (25%) |
| Steroids | |
| no | 5 (11.4%) |
| yes | 39 (88.6%) |
| Vitamin C | 6 (13.6%) |
| Zinc | 5 (11.4%) |
| Maximum Oxygen intervention | |
| Intubation | 7 (15.9%) |
| High flow oxygen | 14 (31.8%) |
| Nasal cannula | 23 (52.2%) |
| Maximum blood test values (mean +/- SD) | |
| CRP | 150.16 ± 69.03 |
| TNF | 30.07 ± 27.08 |
| IL6 | 294.74 ± 565.24 |
| FERRITIN | 3568.16 ± 5362.36 |
| ANC | 2.67 ± 2.21 |